She was a prominent figure in the field of childhood cancer when, in 1974, she helped create the first Ronald McDonald House in Philadelphia.
from NYT > Health https://ift.tt/s3WZPku
via health&fitness
vendredi 30 septembre 2022
Price of New A.L.S. Treatment Will Be $158,000 Per Year, Maker Says
The list price of the therapy, Relyvrio, is much higher than an economic research group recommends, but the company says most patients will pay very little themselves.
from NYT > Health https://ift.tt/GHNw0Vp
via health&fitness
from NYT > Health https://ift.tt/GHNw0Vp
via health&fitness
Half of Adults Have Heard Little or Nothing About New Covid Boosters, Survey Finds
The latest shots, which target Omicron and its subvariants, could offer protection against a winter surge in cases. But many people are unsure if they’re eligible.
from NYT > Health https://ift.tt/fZAxKOt
via health&fitness
from NYT > Health https://ift.tt/fZAxKOt
via health&fitness
Can Smartphones Help Predict Suicide?
A unique research project is tracking hundreds of people at risk for suicide, using data from smartphones and wearable biosensors to identify periods of high danger — and intervene.
from NYT > Health https://ift.tt/gep1GfA
via health&fitness
from NYT > Health https://ift.tt/gep1GfA
via health&fitness
jeudi 29 septembre 2022
Leonard Cole, Who Detailed Secret Army Germ Tests, Dies at 89
A dentist with a parallel career as a political scientist, he drew attention to a program that made millions of Americans unwitting guinea pigs.
from NYT > Health https://ift.tt/Q0AKTr3
via health&fitness
from NYT > Health https://ift.tt/Q0AKTr3
via health&fitness
FDA Approves ALS Treatment Despite Questions About Effectiveness
The drug is safe, and one trial found it may extend survival and slow paralysis in functions like muscle control and speaking. A larger trial will be completed in 2024.
from NYT > Health https://ift.tt/wbE2m5n
via health&fitness
from NYT > Health https://ift.tt/wbE2m5n
via health&fitness
FDA Approves ALS Treatment Despite Questions About Effectiveness
The drug is safe, and one trial found it may extend survival and slow paralysis in functions like muscle control and speaking. A larger trial will be completed in 2024.
from NYT > Health https://ift.tt/unJixBX
via health&fitness
from NYT > Health https://ift.tt/unJixBX
via health&fitness
Inscription à :
Articles (Atom)